Amalya Sargsyan, Medical Oncologist at Yeolyan Oncology and Hematology Center, shared a post on X:
“BGICC 2025 kicked off with 5000 attendees in Cairo, Egypt! Prof. Giuseppe Curigliano set the stage with an inspiring session on DESTINY-Breast06, highlighting the potential of T-DXd in HER2-low/ultralow HR+ mBC.
OncoDaily is here – stay tuned for live podcasts and onsite interviews!”
Further Reading:
BGICC 2025: Hear from Global Oncology Leaders
Introducing the Radiology Course at BGICC 2025
Get Ready for BGICC 2025: A Global Event in Cancer Care
The 17th Annual BGICC Conference Kicks Off in Cairo, Egypt with 5,000 Attendees
Scientific Insights from Prof. Hope Rugo: Advancements in Metastatic HER2+ Breast Cancer Therapy
